Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients
- 4 September 1989
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 87 (3) , S26-S29
- https://doi.org/10.1016/0002-9343(89)90527-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Poor seroconversion rate after hepatitis B vaccination in high-risk institutionalized mentally retarded patientsAmerican Journal of Infection Control, 1986
- Risk of hepatitis B in a ward for mentally retarded HBsAg carriersInfection, 1986
- Survey of Hepatitis B Viral Markers at a Public Day School and a Residential Institution Sharing Mentally Handicapped StudentsThe Journal of Infectious Diseases, 1984
- Immune responses to hepatitis B vaccine in the mentally retardedJournal of Infection, 1983
- An Institutional Outbreak of Hepatitis B Related to a Human Biting CarrierThe Journal of Infectious Diseases, 1982
- Hepatitis B VaccineNew England Journal of Medicine, 1980
- Hepatitis B in a hospital for the mentally subnormal in southern England.BMJ, 1978
- PREVALENCE OF HEPATITIS B INFECTION AMONG RESIDENTS OF AN INSTITUTION FOR THE MENTALLY RETARDEDAmerican Journal of Epidemiology, 1977
- THE EPIDEMIOLOGY OF SERUM HEPATITIS (SH) INFECTIONS: A CONTROLLED STUDY IN TWO CLOSED INSTITUTIONS12American Journal of Epidemiology, 1971
- A Serum Antigen (Australia Antigen) in Down's Syndrome, Leukemia, and HepatitisAnnals of Internal Medicine, 1967